September 2023: The FDA notes reports of Ileus, a gastrointestinal disorder, following use of Ozempic
The prescriber recommendations for weight loss include "those with a BMI of 30 or above or a BMI of at least 27 and a coexisting condition such as diabetes, heart disease or sleep apnea may be considered for these medications," shares Melissa Mitri, M.S., RD, a nutrition writer and owner of Melissa Mitri Nutrition
Patients should not modify the dosage or frequency of any medication without consulting a healthcare provider first
Although there are no standard criteria for the clinical and biomarker evidence required to support disease modification, clinical measures such as a change in trajectory of decline, an increasing drug versus placebo difference over time, an increased time to event, and an enduring change after discontinuation support this terminology
Life Sci (2021) 264:118645